Hemab Therapeutics Announces First Healthy Volunteer Dosed In Phase 1 Trial Of HMB-003 For Heavy Menstrual Bleeding; Says Results Expected No Later Than Mid-2027

Loading news article.

Hemab Therapeutics Announces First Healthy Volunteer Dosed In Phase 1 Trial Of HMB-003 For Heavy Menstrual Bleeding; Says Results Expected No Later Than Mid-2027 | WAPE

Hemab Therapeutics Announces First Healthy Volunteer Dosed In Phase 1 Trial Of HMB-003 For Heavy Menstrual Bleeding; Says Results Expected No Later Than Mid-2027

Article summary

Related companies

Comments —